Public, NASDAQ:REGN
NASDAQ Global Market
Cellectis to receive $12.45 million upfront from Regeneron deal
Date: Fri, 04 Jul 2008 11:26:42 GMT
Tags:
Cellectis to receive $12.45 million upfront from Regeneron deal
Forbes - 23 hours ago
Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology - FOXBusiness
StreetInsider.com (subscription)
Forbes - 23 hours ago
PARIS ( Thomson Financial ) - French biotech company Cellectis said it will receive an upfront payment of $12.45 million from Regeneron Pharmaceuticals Inc for an agreement to allow the US company ...
Regeneron paying $12.45M settlement - Albany Times UnionCellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology - FOXBusiness
StreetInsider.com (subscription)
2008-07-02 16:33:16 - www.companiesandmarkets.com adds new report - Regeneron Pharmaceuticals Inc - Premium Company Profile
Date: Wed, 02 Jul 2008 14:46:22 GMT
Tags:
2008-07-02 16:33:16 - www.companiesandmarkets.com adds new report - Regeneron Pharmaceuticals Inc - Premium Company Profile
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
Regeneron Pharmaceuticals is a biopharmaceutical company mainly focused on the development and commercialization of products for oncology , age - related macular degeneration ( AMD ) , and autoimmune ...
Zacks Analyst Interview Highlights: Celgene, Regeneron, Myriad Genetics, Alkermes and Trimeris
Date: Thu, 26 Jun 2008 10:13:19 GMT
Tags:
Zacks Analyst Interview Highlights: Celgene, Regeneron, Myriad Genetics, Alkermes and Trimeris
Business Wire (press release) - Jun 26, 2008
Business Wire (press release) - Jun 26, 2008
CHICAGO - - ( BUSINESS WIRE ) - - Zacks . com releases the latest Analyst Interview.Today ' s interview is with senior analyst Grant Zeng , who discusses Celgene ( Nasdaq : CELG ) , Regeneron ...
Regeneron Announces Presentation at Jefferies 2 nd Annual Healthcare Conference
Date: Tue, 24 Jun 2008 13:43:02 GMT
Tags:
Regeneron Announces Presentation at Jefferies 2 nd Annual Healthcare Conference
Business Wire (press release) - Jun 24, 2008
Business Wire (press release) - Jun 24, 2008
TARRYTOWN , NY - - ( BUSINESS WIRE ) - - Regeneron Pharmaceuticals , Inc . ( Nasdaq : REGN ) will webcast its presentation at the Jefferies 2 nd Annual Healthcare Conference on Thursday , June ...
Zacks Analyst Interview Highlights: Celgene, Regeneron, Myriad Genetics, Alkermes and Trimeris
Date: Thu, 12 Jun 2008 10:15:57 GMT
Tags:
Zacks Analyst Interview Highlights: Celgene, Regeneron, Myriad Genetics, Alkermes and Trimeris
Business Wire (press release) - Jun 12, 2008
Business Wire (press release) - Jun 12, 2008
CHICAGO - - ( BUSINESS WIRE ) - - Zacks . com releases the latest Analyst Interview.Today ' s interview is with senior analyst Grant Zeng , who discusses Celgene ( Nasdaq : CELG ) , Regeneron ...
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)
Date: Thu, 3 Jul 2008 16:01:11 Etc/GMT
Tags:
BioMarin, Myriad, and Regeneron Show a Quiet Strength (at Seeking Alpha)
Date: Thu, 26 Jun 2008 12:55:29 Etc/GMT
Tags:
Investor Focus: Biotech's 2Q winners and losers (AP)
Date: Tue, 24 Jun 2008 19:31:20 Etc/GMT
Tags:
Clinical developments and sales outlooks boosted shares of Vertex Pharmaceuticals and Gilead Sciences Inc. during the quarter, placing them among the top gainers in the biotechnology sector during the second quarter.
Regeneron Announces Presentation at Jefferies 2nd Annual Healthcare Conference (Business Wire)
Date: Tue, 24 Jun 2008 13:30:00 Etc/GMT
Tags:
TARRYTOWN, N.Y.----Regeneron Pharmaceuticals, Inc. will webcast its presentation at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, 2008. The presentation will provide an overview of the Company and its clinical programs and is scheduled to be broadcast live on Thursday, June 26 at 12:30 p.m.
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Tue, 17 Jun 2008 20:01:13 Etc/GMT
Tags: